Form 4 for SURG SurgePays, Inc.
Accepted 2025-05-27 00:00:00 ET · period of report 2025-05-22 · accession 0001641172-25-012495 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-05-27 | 2025-05-22 | SURG | Weisberg Laurie | Dir | A - Grant | $0.00 | +50.0K | 57.8K | +640% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Restricted Shares (Common Stock) | 2025-05-22 | A | A | 50,000 | $0.00 | 57,809 | D | — | — | (F1) These shares were issued pursuant to the provisions of the SurgePays, Inc. 2022 Omnibus Securities and Incentive Plan (the "2022 Plan") and a Restricted Share Award Agreement, dated May 22, 2025, by and between SurgePays, Inc. (the "Company") and Ms. Weisberg (the "RSA Agreement"). The RSA Agreement provides that the shares will not vest until the earliest to occur of (a) the director no longer serves as a director of the Company for any reason (including, but not limited to, upon death or disability that renders the director incapable of providing services to the Company) other than a Termination of Service for Cause (as defined in the RSA Agreement); (b) upon the occurrence of a Change in Control (as defined in the 2022 Plan); or (c) August 8, 2028. |